Atrial natriuretic polypeptides elevate the level of cyclic GMP in the rat choroid plexus

Neurosci Lett. 1987 Aug 18;79(1-2):174-8. doi: 10.1016/0304-3940(87)90692-6.

Abstract

We studied the effect of synthetic rat alpha-atrial natriuretic polypeptide (1-28) (ANF-(99-126)) and related atrial natriuretic polypeptides on the accumulation of cyclic GMP (cGMP) in isolated rat choroid plexus in vitro, the objective being to determine whether ANF-(99-126) binding sites are physiologically active receptors. One microM of ANF-(99-126) increased the level of cGMP within 30 s and the accumulation reached the maximum level 5 min after adding of ANF-(99-126) to the incubation media. Significant increase in the level of cGMP depended on concentrations of the ANF-(99-126), ANF-(101-126) and ANF-(103-125), with a range of 10.0 nM to 10.0 microM. These data indicate that binding sites for ANF-(99-126) in the rat choroid plexus may be physiologically active receptors, possibly linked to the production of cerebrospinal fluid.

MeSH terms

  • Animals
  • Atrial Natriuretic Factor / pharmacology*
  • Choroid Plexus / drug effects
  • Choroid Plexus / metabolism*
  • Cyclic GMP / metabolism*
  • In Vitro Techniques
  • Male
  • Rats
  • Rats, Inbred Strains
  • Time Factors

Substances

  • Atrial Natriuretic Factor
  • Cyclic GMP